ERBB2 and breast cancer: It found that except for luminal A (P > 0.05) (Additional file 1: Fig. S4), the high expression of HNRNPC was associated with poor prognosis of basal-like, HER2 + , luminal B and normal-like BC patients (P < 0.05) (Fig. 5E–H).